Close Menu

Michael Arrington has a post at the TechCrunch blog about his own experience sending in his DNA to 23andMe. Before you let out a "been there, done that" yawn, GTO has this to say -- Arrington raises a great issue that we haven't seen in anyone else's posts so far. What if, he asks, he just sends in someone else's DNA under his own name? Sure, a service company like 23andMe could easily distinguish male DNA from female.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.